Mortality and years of life lost of colorectal cancer in China, 2005-2020: findings from the national mortality surveillance system.
10.1097/CM9.0000000000001625
- Author:
Wei WANG
1
;
Peng YIN
;
Yun-Ning LIU
;
Jiang-Mei LIU
;
Li-Jun WANG
;
Jin-Lei QI
;
Jin-Ling YOU
;
Lin LIN
;
Shi-Di MENG
;
Fei-Xue WANG
;
Mai-Geng ZHOU
Author Information
1. National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
- Publication Type:Journal Article
- MeSH:
China/epidemiology*;
Colorectal Neoplasms;
Humans
- From:
Chinese Medical Journal
2021;134(16):1933-1940
- CountryChina
- Language:English
-
Abstract:
BACKGROUND:Colorectal cancer (CRC) is the fourth cause of cancer death in China. We aimed to provide national and subnational estimates and changes of CRC premature mortality burden during 2005-2020.
METHODS:Data from multi-source on the basis of the national surveillance mortality system were used to estimate mortality and years of life lost (YLL) of CRC in the Chinese population during 2005-2020. Estimates were generated and compared for 31 provincial-level administrative divisions in China.
RESULTS:Estimated CRC deaths increased from 111.41 thousand in 2005 to 178.02 thousand in 2020; age-standardized mortality rate decreased from 10.01 per 100,000 in 2005 to 9.68 per 100,000 in 2020. Substantial reduction in CRC premature mortality burden, as measured by age-standardized YLL rate, was observed with a reduction of 10.20% nationwide. Marked differences were observed in the geographical patterns of provincial units, and they appeared to be obvious in areas with higher economic development. Population aging was the dominant driver which contributed to the increase in CRC deaths, followed by population growth and age-specific mortality change.
CONCLUSIONS:Substantial discrepancies were observed in the premature mortality burden of CRC across China. Targeted considerations were needed to promote a healthy lifestyle, expand cost-effective CRC early screening and diagnosis, and improve medical treatment to reduce CRC mortality among high-risk populations and regions with inadequate healthcare resources.
